From what I understand, the requirements for the Afrezza trial are pretty rigid and I'd have to have a higher A1c to participate. My use of Bydureon also excludes me from some other trials but I'm not sure of the Afrezza trial.

I am told that almost all type 2's will eventually require insulin. I would use Afrezza without any hesitation. Back in 2008 I invested in AMLN knowing it was a great advancement in the treatment of diabetes. I plowed a lot of my profit into MNKD and have doubled my position in the past 3 months. What makes it even more exciting is the pps I paid has almost decreased my average share price by 50%.

I see nothing but blue sky when Afrezza is approved. But, as I use to say on the Amylin board the money is great but the benefit to the world is the real payday.